HCW Biologics (HCWB) Insider Trading & Ownership $0.26 -0.06 (-20.03%) Closing price 01/29/2025 04:00 PM EasternExtended Trading$0.25 -0.01 (-4.67%) As of 01/29/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCW Biologics (NASDAQ:HCWB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage49.90%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$610,262.28Number OfInsiders Selling(Last 3 Years)0 Get HCWB Insider Trade Alerts Want to know when executives and insiders are buying or selling HCW Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HCWB Insider Buying and Selling by Quarter HCW Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/14/2023Hing C WongCEOBuy1,800$2.08$3,744.00 9/13/2023Gary M WinerDirectorBuy546$2.05$1,119.30 9/13/2023Rebecca ByamCFOBuy5,000$2.10$10,500.00 9/11/2023Gary M WinerDirectorBuy99$2.05$202.95 9/11/2023Rebecca ByamCFOBuy5,000$2.05$10,250.00 9/8/2023Rebecca ByamCFOBuy5,000$2.02$10,100.00 9/7/2023Gary M WinerDirectorBuy63$1.95$122.85 9/6/2023Rebecca ByamCFOBuy5,000$1.95$9,750.00 9/5/2023Gary M WinerDirectorBuy400$1.75$700.00 6/9/2023Rebecca ByamCFOBuy20,000$2.06$41,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/8/2023Lee FlowersSVPBuy10,000$2.16$21,600.00 6/7/2023Rebecca ByamCFOBuy20,000$2.03$40,600.00 6/5/2023Rebecca ByamCFOBuy20,000$1.67$33,400.00 6/1/2023Hing C WongCEOBuy800$1.62$1,296.00 5/30/2023Gary M WinerDirectorBuy850$1.52$1,292.00 5/30/2023Hing C WongCEOBuy3,000$1.55$4,650.00 5/26/2023Rebecca ByamCFOBuy20,000$1.66$33,200.00 5/24/2023Rebecca ByamCFOBuy20,000$1.61$32,200.00 5/22/2023Rebecca ByamCFOBuy33,450$1.53$51,178.50 9/14/2022Rebecca ByamCFOBuy15,000$2.58$38,700.00 9/12/2022Rebecca ByamCFOBuy15,000$2.65$39,750.00 9/8/2022Hing C WongCEOBuy4,000$2.67$10,680.00 8/29/2022Rebecca ByamCFOBuy10,000$2.57$25,700.00 8/26/2022Rebecca ByamCFOBuy10,000$2.54$25,400.00 8/24/2022Rebecca ByamCFOBuy50,000$2.50$125,000.00 6/13/2022Rebecca ByamCFOBuy7,596$2.08$15,799.68 6/10/2022Gary M WinerDirectorBuy1,500$2.13$3,195.00 6/9/2022Hing C WongCEOBuy2,000$2.25$4,500.00 6/8/2022Gary M WinerDirectorBuy1,000$2.27$2,270.00 6/6/2022Gary M WinerDirectorBuy1,000$2.13$2,130.00 6/2/2022Rick S GreeneDirectorBuy4,800$2.09$10,032.00 (Data available from 1/1/2013 forward) HCWB Insider Trading Activity - Frequently Asked Questions Who is on HCW Biologics's Insider Roster? The list of insiders at HCW Biologics includes Gary M Winer, Hing C Wong, Lee Flowers, Rebecca Byam, and Rick S Greene. Learn more on insiders at HCWB. What percentage of HCW Biologics stock is owned by insiders? 49.90% of HCW Biologics stock is owned by insiders. Learn more on HCWB's insider holdings. Which HCW Biologics insiders have been buying company stock? The following insiders have purchased HCWB shares in the last 24 months: Gary M Winer ($3,437.10), Hing C Wong ($9,690.00), Lee Flowers ($21,600.00), and Rebecca Byam ($272,378.50). How much insider buying is happening at HCW Biologics? Insiders have purchased a total of 171,008 HCWB shares in the last 24 months for a total of $307,105.60 bought. HCW Biologics Key ExecutivesDr. Hing C. Wong Ph.D. (Age 70)Founder, CEO, Director & Secretary Compensation: $421.05kMs. Rebecca Byam CPA (Age 68)M.B.A., Chief Financial Officer Compensation: $297.08kDr. Peter Rhode Ph.D. (Age 66)Chief Scientific Officer & VP of Clinical Operations Compensation: $248.57kMs. Nicole Valdivieso Esq.Vice President of Legal AffairsMs. Raquel Diaz M.S.Director of Human ResourcesMr. Lee D. Flowers (Age 78)Senior Vice President of Business Development More Insider Trading Tools from MarketBeat Related Companies ALVR Insider Ownership LTRN Insider Ownership FGEN Insider Ownership RPTX Insider Ownership SPRO Insider Ownership OTLK Insider Ownership ICCC Insider Ownership KZR Insider Ownership VTVT Insider Ownership ALRN Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:HCWB) was last updated on 1/30/2025 by MarketBeat.com Staff From Our Partners#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredHot Stock Alert! Biotech innovator on the NYSE announces breakthrough antiviral therapyA revolutionary antiviral drug is here! This breakthrough could mean viruses are unlikely to escape treatment....Smallcaps Daily | SponsoredThe #1 Stock for Trump’s Second Term?Imagine how much money you could make if you bought all of the top performing stocks during Trump's second ter...InvestorPlace | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
